TREATMENT PERSPECTIVES IN LOCALLY ADVANCED UNRESECTABLE PANCREATIC-CANCER

被引:34
|
作者
JEEKEL, J
TREURNIETDONKER, AD
机构
[1] Department of Surgery, University Hospital Dijkzigt, Rotterdam, 3015 GD
关键词
D O I
10.1002/bjs.1800781121
中图分类号
R61 [外科手术学];
学科分类号
摘要
Locally advanced unresectable pancreatic cancer is sometimes encountered without manifest distant metastases. Twenty patients with histologically proven unresectable pancreatic cancer without distant metastases were treated with radiotherapy and 5-fluorouracil (5-FU). Radiotherapy consisted of 50 Gy external upper abdomen radiation in two courses, concomitant with intravenous 5-FU 375 mg/m2 given as a bolus injection 4-6 h before radiation on the first 4 days of each treatment course. The treatment protocol was completed in 18 patients without complications. The median survival time was 10 months which compares favourably with a 3-5 months median survival time when treatment is withheld. Nine patients (45 per cent) were alive at 1 year, two patients at 2, 3 and 4 years. A second-look operation was performed in four patients 6, 11, 12 and 22 months after completion of radiotherapy. In two patients the tumour could be resected. It appears that treatment with radiotherapy and 5-FU may benefit patients with locally advanced unresectable pancreatic cancer.
引用
收藏
页码:1332 / 1334
页数:3
相关论文
共 50 条
  • [31] PERSPECTIVES IN CHEMOTHERAPY OF PANCREATIC-CANCER
    KLAPDOR, R
    EUROPEAN JOURNAL OF SURGICAL ONCOLOGY, 1991, 17 (02): : 153 - 166
  • [32] UNRESECTABLE PANCREATIC-CANCER - WHAT IS THE OPTIMAL PROCEDURE
    MOSDELL, DM
    KESSLER, C
    MORRIS, DM
    SOUTHERN MEDICAL JOURNAL, 1991, 84 (05) : 571 - 574
  • [33] CURRENT STATUS OF CHEMOTHERAPY IN TREATMENT OF ADVANCED PANCREATIC-CANCER
    SCHEITHAUER, W
    TUMORDIAGNOSTIK & THERAPIE, 1984, 5 (02) : 44 - 48
  • [34] Current perspectives on locally advanced pancreatic cancer - Review
    Wolff, RA
    ONCOLOGY-NEW YORK, 2000, 14 (11): : 1549 - +
  • [35] THE IMPORTANCE OF TREATMENT SEQUENCING FOR OPTIMIZING THE SURVIVAL BENEFIT OF PATIENTS WITH LOCALLY UNRESECTABLE PANCREATIC-CANCER TREATED BY RADIATION AND ADRIAMYCIN THERAPY
    DOUGLASS, HO
    NAVA, HR
    SUBRAMANIAN, N
    THOMAS, PRM
    DIGESTIVE DISEASES AND SCIENCES, 1987, 32 (10) : 1164 - 1164
  • [36] Evolving Treatment Options for Locally Advanced Unresectable Pancreatic Ductal Adenocarcinoma
    Cinar, Pelin
    Ko, Andrew H.
    JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2014, 12 (02): : 167 - 172
  • [37] Proton Therapy for Unresectable and Medically Inoperable Locally Advanced Pancreatic Cancer
    Gawish, Ahmed
    Eberle, Fabian
    Schymalla, Markus
    Vorwerk, Hilke
    Adeberg, Sebastian
    RADIOTHERAPY AND ONCOLOGY, 2024, 194 : S2281 - S2283
  • [38] Prognostic factors and sites of metastasis in unresectable locally advanced pancreatic cancer
    Peixoto, Renata D'Alpino
    Speers, Caroline
    McGahan, Colleen E.
    Renouf, Daniel J.
    Schaeffer, David F.
    Kennecke, Hagen F.
    CANCER MEDICINE, 2015, 4 (08): : 1171 - 1177
  • [39] Chemoradiation for Locally Advanced Unresectable Pancreatic Cancer-What Now?
    Vaccaro, Gina
    Lopez, Charles D.
    JAMA ONCOLOGY, 2017, 3 (06) : 850 - 851
  • [40] Proton Therapy for Unresectable and Medically Inoperable Locally Advanced Pancreatic Cancer
    Gawish, Ahmed
    Eberle, Fabian
    Vorwerk, Hilke
    Adeberg, Sebastian
    ONCOLOGY RESEARCH AND TREATMENT, 2024, 47 : 238 - 238